Here's a nice piece of gobbldeegook from the Allergan PR on the TBRA buyout...

Quote:

---

"The acquisition of Tobira is a strategic R&D investment within a white space area of our global gastroenterology franchise and an opportunity to advance the development

---

Translation...we think we can make some serious money on this mofo! LOL